Cite
HARVARD Citation
Blevins, T. et al. (2020). Efficacy and safety of MYL‐1501D versus insulin glargine in people with type 1 diabetes mellitus: Results of the INSTRIDE 3 phase 3 switch study. Diabetes, obesity & metabolism. 22 (3), pp. 365-372. [Online].